Provided by Tiger Fintech (Singapore) Pte. Ltd.

Studio City International Holdings Ltd

2.96
+0.0000
Post-market: 2.960.00000.00%16:05 EDT
Volume:3.40K
Turnover:10.29K
Market Cap:570.06M
PE:-5.87
High:3.12
Open:2.99
Low:2.96
Close:2.96
Loading ...

Bank of America (BAC): Among the Best Fortune 500 Stocks to Buy According to Hedge Funds

Insider Monkey
·
26 Feb

Is Bank of America Corporation (BAC) Buying Back Its Stock in 2025?

Insider Monkey
·
25 Feb

Keefe, Bruyette & Woods Initiates MSC Income Fund at Market Perform With $17.50 Price Target

MT Newswires Live
·
25 Feb

Excel Force MSC Malaysia 2nd-Quarter 2024 Earnings Summary Table

Dow Jones
·
25 Feb

MSC Income Fund initiated with a Market Perform at Keefe Bruyette

TIPRANKS
·
25 Feb

MSC Income Fund Initiated at Market Perform by Raymond James

Dow Jones
·
24 Feb

Is Bank of America Corporation (BAC) the Best DRIP Stock to Own Now?

Insider Monkey
·
24 Feb

Raymond James Initiates MSC Income Fund at Market Perform

MT Newswires Live
·
24 Feb

Truist Securities Initiates MSC Income Fund at Buy With $20 Price Target

MT Newswires Live
·
24 Feb

Buy Rating Affirmed for MSC Income Fund, Inc. Due to Strong Growth Potential and Strategic Positioning

TIPRANKS
·
24 Feb

MSC Income Fund initiated with a Market Perform at Raymond James

TIPRANKS
·
24 Feb

MSC Income Fund initiated with a Buy at Truist

TIPRANKS
·
24 Feb

Studio City Announces Earnings Release Date

GlobeNewswire
·
24 Feb

MSC Income Fund initiated with a Market Perform at Citizens JMP

TIPRANKS
·
24 Feb

MSC Income Fund, Inc. (MSIF) Receives a Hold from JMP Securities

TIPRANKS
·
24 Feb

Dr. Gregory George MD PhD Joins Mesoblast Board

GlobeNewswire
·
24 Feb

Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025

GlobeNewswire
·
21 Feb

Bank of America (BAC) Stock Slides as Market Rises: Facts to Know Before You Trade

Zacks
·
20 Feb

MSC INDUSTRIAL SUPPLY CO. TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES

PR Newswire
·
19 Feb

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

GlobeNewswire
·
18 Feb